Lianjiao Dai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lianjiao Dai has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Chuanqing Xu
School of Science, Beijing University of Civil Engineering and Architecture, Beijing, China
1 shared publication - Kedeng Cheng
School of Mathematics, Statistics and Mechanics, Beijing University of Technology, Beijing, 100124, China
1 shared publication - Songbai Guo
School of Science, Beijing University of Civil Engineering and Architecture, Beijing 102616, P. R. China
1 shared publication - Xiaoling Liu
Department of Mathematics, Hanshan Normal University Chaozhou, Guangdong, P. R. China
1 shared publication
Latest Publications
- 28 December 2023
- Published by World Scientific Pub Co Pte Ltd in International Journal of Biomathematics
- Vol. 18 (02)
Demand assessment of the number of inpatient beds in China based on the COVID-19 dynamical model
COVID-19 is a worldwide pandemic that poses a great threat to people’s health and has a huge impact on economic and social life. The epidemic is currently at a low level, but is still prevalent worldwide. Therefore, it is still important to study the prevention and control of the spread of the COVID-19 epidemic. We collected the numbers of COVID-19 infections in China during the past three years, and obtained the regional distribution of outbreaks through analysis. To assess the capacity of medical resources in these regions in response to the outbreaks of COVID-19, we developed a model of COVID-19 transmission dynamics including mild and severe cases. The simulation showed that 11 regions, Beijing, Shanghai, Heilongjiang, Yunnan, Xinjiang, Inner Mongolia, Liaoning, Jilin, Hainan, Guangdong and Fujian, all have a serious shortage of medical beds in reserve. When facing the next new outbreak, these areas will have insufficient medical resources. We simulated the effects of drug effectiveness and the proportion of asymptomatic infected individuals on the spread of the epidemic, and obtained that an accurate determination of the proportion of asymptomatic patients in the population is crucial to the impact on healthcare resources, while improving the effectiveness of drugs can significantly reduce the burden on healthcare resources. Regions should invest more in healthcare and increase more medical resources, including medical beds. Government should accelerate the development of effective COVID-19 drugs to effectively control the scale of the outbreak. The proportion of asymptomatic patients in the population has a significant impact on the allocation of healthcare resources. The monitoring of antibody levels in the population should be strengthened to better control the spread of the epidemic.
- 28 December 2023
- Published by World Scientific Pub Co Pte Ltd in International Journal of Biomathematics
- Vol. 18 (02)
Demand assessment of the number of inpatient beds in China based on the COVID-19 dynamical model
COVID-19 is a worldwide pandemic that poses a great threat to people’s health and has a huge impact on economic and social life. The epidemic is currently at a low level, but is still prevalent worldwide. Therefore, it is still important to study the prevention and control of the spread of the COVID-19 epidemic. We collected the numbers of COVID-19 infections in China during the past three years, and obtained the regional distribution of outbreaks through analysis. To assess the capacity of medical resources in these regions in response to the outbreaks of COVID-19, we developed a model of COVID-19 transmission dynamics including mild and severe cases. The simulation showed that 11 regions, Beijing, Shanghai, Heilongjiang, Yunnan, Xinjiang, Inner Mongolia, Liaoning, Jilin, Hainan, Guangdong and Fujian, all have a serious shortage of medical beds in reserve. When facing the next new outbreak, these areas will have insufficient medical resources. We simulated the effects of drug effectiveness and the proportion of asymptomatic infected individuals on the spread of the epidemic, and obtained that an accurate determination of the proportion of asymptomatic patients in the population is crucial to the impact on healthcare resources, while improving the effectiveness of drugs can significantly reduce the burden on healthcare resources. Regions should invest more in healthcare and increase more medical resources, including medical beds. Government should accelerate the development of effective COVID-19 drugs to effectively control the scale of the outbreak. The proportion of asymptomatic patients in the population has a significant impact on the allocation of healthcare resources. The monitoring of antibody levels in the population should be strengthened to better control the spread of the epidemic.